HENDERSON, Nev.–(BUSINESS WIRE)–United Health Products, Inc. (OTC: UEEC), (“UHP” or the “company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose that is patented through Oct 2029 (US Patent 8,557,874 Oct 15,2013) for the healthcare and wound care sectors, today announced that is has recently received correspondence from the FDA regarding its current PMA class […]
News
United Health Products Issues Progress Report
HENDERSON, Nev.–(BUSINESS WIRE)–United Health Products, Inc. (OTC: UEEC) (UHP or the company) today announced that it is proceeding with its Premarket Approval (PMA) application for Class III approval to the FDA for HemoStyp®. In this current difficult environment, UHP has been working continuously with the FDA to advance its application, and has been working towards […]